data_5wrx_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 5wrx _Structure_validation_residue.Date_analyzed 2017-05-05 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 96.4 t . . . . . 0 C--O 1.23 0.046 0 CA-C-O 120.849 0.357 . . . . 73.51 111.136 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -120.82 -56.3 1.95 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.166 -0.47 . . . . 74.31 111.079 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 3.0 mtt180 -120.5 -74.2 0.62 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.456 . . . . 71.33 110.882 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -117.82 1.93 17.53 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.774 -0.727 . . . . 63.14 112.489 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.452 ' CZ2' ' HB3' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -51.66 92.5 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.751 0.31 . . . . 75.41 110.951 -179.967 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -94.91 -79.51 1.46 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.723 -0.751 . . . . 62.23 112.487 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 12.9 mtm-85 -116.75 -78.67 0.58 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.83 0.348 . . . . 72.25 110.848 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.17 31.74 5.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.171 -0.468 . . . . 74.43 110.908 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.8 m -121.04 75.45 29.37 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.595 0.712 . . . . 73.43 110.891 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.452 ' HB3' ' CZ2' ' A' ' 5' ' ' TRP . 54.0 Cg_endo -69.76 132.09 22.6 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.696 2.264 . . . . 75.34 112.347 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -120.53 27.55 8.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 73.41 110.916 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.536 ' N ' ' CD2' ' A' ' 12' ' ' PHE . 0.1 OUTLIER -123.73 26.78 7.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 75.23 110.938 179.907 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.265 0 C-N-CA 120.686 -0.768 . . . . 71.2 112.495 -179.964 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 96.5 t . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.845 0.355 . . . . 71.42 111.113 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -120.77 -56.32 1.95 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.456 . . . . 41.12 111.127 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 4.4 mtt180 -120.54 -74.13 0.62 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.464 . . . . 74.02 110.875 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -117.89 2.07 17.35 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.735 -0.745 . . . . 64.22 112.48 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.453 ' CZ2' ' HB3' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -51.86 92.44 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.796 0.331 . . . . 75.41 110.927 -179.934 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -95.02 -80.19 1.49 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.727 -0.749 . . . . 73.01 112.509 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.57 -79.04 0.58 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.869 0.366 . . . . 73.45 110.921 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.25 32.31 5.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.464 . . . . 71.33 110.853 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 65.1 m -121.36 75.56 32.78 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.554 0.693 . . . . 74.02 110.833 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.453 ' HB3' ' CZ2' ' A' ' 5' ' ' TRP . 53.7 Cg_endo -69.75 132.15 22.74 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.637 2.225 . . . . 73.45 112.324 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -120.53 27.59 8.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.185 -0.461 . . . . 63.44 110.922 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.547 ' N ' ' CD1' ' A' ' 12' ' ' PHE . 0.1 OUTLIER -123.79 25.99 7.84 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.162 -0.472 . . . . 65.34 110.913 179.897 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.28 0 C-N-CA 120.756 -0.735 . . . . 73.41 112.44 -179.95 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 96.7 t . . . . . 0 N--CA 1.458 -0.053 0 CA-C-O 120.856 0.36 . . . . 75.43 111.147 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -120.79 -56.26 1.96 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.136 -0.484 . . . . 64.44 111.096 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 4.8 mtt85 -120.58 -74.16 0.62 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.249 -0.432 . . . . 65.42 110.893 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -117.85 2.03 17.44 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.765 -0.731 . . . . 71.42 112.492 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.455 ' CZ2' ' HB3' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -51.87 92.51 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.8 0.333 . . . . 75.51 110.903 -179.904 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -95.01 -80.24 1.5 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.738 -0.744 . . . . 72.45 112.5 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 11.2 mtp85 -115.55 -79.08 0.58 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.896 0.379 . . . . 75.32 110.874 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.2 32.28 5.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.161 -0.472 . . . . 75.31 110.897 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 82.8 m -121.36 75.57 32.71 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.603 0.716 . . . . 65.33 110.879 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.455 ' HB3' ' CZ2' ' A' ' 5' ' ' TRP . 53.8 Cg_endo -69.74 132.09 22.63 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.695 2.263 . . . . 74.33 112.371 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -120.48 27.54 8.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.214 -0.448 . . . . 74.51 110.899 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.545 ' N ' ' CD1' ' A' ' 12' ' ' PHE . 0.1 OUTLIER -123.81 26.07 7.8 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.209 -0.45 . . . . 75.12 110.896 179.957 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.319 0 C-N-CA 120.751 -0.737 . . . . 73.55 112.459 -179.976 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 96.6 t . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.934 0.397 . . . . 73.24 111.15 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -120.85 -56.27 1.95 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.11 -0.495 . . . . 72.31 111.052 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 1.9 mtt180 -120.55 -74.2 0.62 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 75.31 110.869 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -117.84 2.04 17.45 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.72 -0.752 . . . . 73.51 112.438 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.45 ' CZ2' ' HB3' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -51.83 92.48 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.823 0.344 . . . . 74.42 110.904 -179.903 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -95.04 -80.3 1.5 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.764 -0.731 . . . . 51.3 112.483 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.3 mtp180 -115.47 -79.08 0.58 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.907 0.384 . . . . 75.34 110.864 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.2 32.24 5.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 73.41 110.877 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 35.8 m -121.32 75.57 32.32 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.605 0.717 . . . . 64.14 110.901 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.45 ' HB3' ' CZ2' ' A' ' 5' ' ' TRP . 53.3 Cg_endo -69.79 132.12 22.61 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.707 2.272 . . . . 74.04 112.306 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -120.48 27.52 8.52 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.184 -0.462 . . . . 72.11 110.909 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.552 ' N ' ' CD1' ' A' ' 12' ' ' PHE . 0.1 OUTLIER -123.79 26.77 7.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.451 . . . . 71.54 110.912 179.915 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 C-N-CA 120.72 -0.753 . . . . 73.34 112.507 -179.973 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 96.6 t . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.852 0.358 . . . . 75.55 111.145 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -120.77 -56.26 1.96 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.204 -0.453 . . . . 72.41 111.099 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -120.51 -74.25 0.62 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.217 -0.447 . . . . 73.15 110.852 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -117.82 2.02 17.51 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.75 -0.738 . . . . 71.34 112.443 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.445 ' CD1' ' CE1' ' A' ' 12' ' ' PHE . 0.0 OUTLIER -51.86 92.42 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.783 0.325 . . . . 74.41 110.947 -179.917 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -94.98 -80.23 1.5 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.703 -0.761 . . . . 71.04 112.502 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 4.0 mtt85 -115.52 -79.05 0.58 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.924 0.392 . . . . 73.12 110.887 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.22 32.22 5.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 75.11 110.922 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 3.2 m -121.31 75.6 32.31 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.575 0.702 . . . . 73.23 110.87 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.444 ' HB3' ' CZ2' ' A' ' 5' ' ' TRP . 53.5 Cg_endo -69.78 132.17 22.74 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.692 2.262 . . . . 72.35 112.309 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -120.53 27.5 8.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.234 -0.439 . . . . 72.34 110.901 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.552 ' N ' ' CD1' ' A' ' 12' ' ' PHE . 0.1 OUTLIER -123.76 26.22 7.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 75.32 110.911 179.943 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.318 0 C-N-CA 120.721 -0.752 . . . . 70.42 112.497 -179.941 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 96.6 t . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.811 0.338 . . . . 74.32 111.108 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -120.85 -56.33 1.95 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.133 -0.485 . . . . 70.41 111.108 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -120.49 -74.15 0.62 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 73.35 110.893 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -117.96 2.11 17.17 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.712 -0.756 . . . . 70.45 112.45 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.45 ' CZ2' ' HB3' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -51.84 92.52 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.853 0.359 . . . . 54.15 110.938 -179.961 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -95.05 -80.21 1.5 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.762 -0.732 . . . . 74.55 112.497 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 44.7 mtt180 -115.62 -79.05 0.58 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.847 0.356 . . . . 71.33 110.873 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.25 32.25 5.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 74.32 110.89 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 72.4 m -121.33 75.57 32.4 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.625 0.726 . . . . 74.42 110.881 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.45 ' HB3' ' CZ2' ' A' ' 5' ' ' TRP . 53.7 Cg_endo -69.71 132.06 22.62 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.71 2.274 . . . . 74.21 112.365 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -120.48 27.57 8.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.282 -0.417 . . . . 63.5 110.897 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.541 ' N ' ' CD1' ' A' ' 12' ' ' PHE . 0.1 OUTLIER -123.79 26.18 7.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 74.4 110.843 179.963 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.283 0 C-N-CA 120.735 -0.745 . . . . 51.42 112.446 -179.917 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 96.4 t . . . . . 0 N--CA 1.457 -0.091 0 CA-C-O 120.878 0.371 . . . . 74.25 111.136 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -120.8 -56.24 1.96 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.124 -0.489 . . . . 75.1 111.096 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 13.2 mtt85 -120.5 -74.3 0.62 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 73.3 110.861 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -117.75 1.94 17.69 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.764 -0.731 . . . . 74.53 112.487 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.449 ' CZ2' ' HB3' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -51.83 92.44 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.795 0.331 . . . . 75.33 110.914 -179.877 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -94.99 -80.27 1.5 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.718 -0.753 . . . . 73.21 112.496 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 5.0 mtp180 -115.48 -79.05 0.58 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.863 0.363 . . . . 74.12 110.9 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.23 32.26 5.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.469 . . . . 75.22 110.875 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 33.9 m -121.38 75.58 32.95 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.621 0.724 . . . . 64.05 110.926 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.449 ' HB3' ' CZ2' ' A' ' 5' ' ' TRP . 54.0 Cg_endo -69.71 132.18 22.85 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.638 2.225 . . . . 74.43 112.359 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -120.52 27.53 8.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.218 -0.446 . . . . 74.14 110.906 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.545 ' N ' ' CD2' ' A' ' 12' ' ' PHE . 0.1 OUTLIER -123.78 26.77 7.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 75.23 110.862 179.966 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.309 0 C-N-CA 120.706 -0.759 . . . . 54.55 112.464 -179.959 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 96.6 t . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.84 0.352 . . . . 72.22 111.143 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -120.77 -56.28 1.96 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 60.15 111.147 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -120.52 -74.21 0.62 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.19 -0.459 . . . . 72.12 110.882 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -117.79 2.01 17.6 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.765 -0.731 . . . . 62.42 112.468 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.449 ' CZ2' ' HB3' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -51.88 92.45 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.813 0.34 . . . . 74.21 110.894 -179.894 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -94.98 -80.2 1.49 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.726 -0.749 . . . . 63.32 112.494 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 8.6 mtt180 -115.56 -79.06 0.58 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.916 0.389 . . . . 74.14 110.898 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.21 32.24 5.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.116 -0.493 . . . . 74.24 110.924 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 90.4 m -121.33 75.57 32.39 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.63 0.729 . . . . 72.03 110.88 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.449 ' HB3' ' CZ2' ' A' ' 5' ' ' TRP . 54.6 Cg_endo -69.7 132.06 22.63 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.736 2.291 . . . . 74.22 112.366 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -120.49 27.59 8.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.23 -0.441 . . . . 74.33 110.97 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.542 ' N ' ' CD2' ' A' ' 12' ' ' PHE . 0.1 OUTLIER -123.83 26.33 7.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.47 . . . . 74.32 110.876 179.953 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 C-N-CA 120.726 -0.75 . . . . 62.01 112.454 -179.964 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 96.4 t . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.813 0.339 . . . . 75.14 111.087 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -120.78 -56.3 1.95 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.459 . . . . 74.23 111.092 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 19.7 mtt180 -120.56 -74.18 0.62 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.238 -0.437 . . . . 73.33 110.904 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -117.87 2.08 17.39 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.704 -0.76 . . . . 64.22 112.461 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.446 ' CD1' ' CE2' ' A' ' 12' ' ' PHE . 0.0 OUTLIER -51.87 92.43 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.798 0.333 . . . . 74.42 110.92 -179.921 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -95.01 -80.24 1.5 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.758 -0.734 . . . . 54.1 112.486 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 3.1 mtt180 -115.51 -79.08 0.58 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.84 0.353 . . . . 73.1 110.883 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.21 32.25 5.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.449 . . . . 71.43 110.874 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.6 m -121.34 75.64 32.58 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.629 0.728 . . . . 64.13 110.901 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.442 ' HB3' ' CZ2' ' A' ' 5' ' ' TRP . 54.0 Cg_endo -69.77 132.11 22.62 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.648 2.232 . . . . 72.24 112.349 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -120.44 27.46 8.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.231 -0.44 . . . . 74.44 110.955 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.549 ' N ' ' CD2' ' A' ' 12' ' ' PHE . 0.1 OUTLIER -123.79 26.77 7.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 73.54 110.893 179.946 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.318 0 C-N-CA 120.748 -0.739 . . . . 42.25 112.497 -179.984 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 96.4 t . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.84 0.352 . . . . 74.01 111.076 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -120.83 -56.2 1.96 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.194 -0.457 . . . . 74.35 111.095 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 12.7 mtp180 -120.6 -74.17 0.62 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.45 . . . . 75.0 110.838 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -117.83 2.04 17.49 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.777 -0.725 . . . . 73.12 112.491 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.451 ' CZ2' ' HB3' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -51.93 92.54 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.841 0.353 . . . . 74.34 110.917 -179.874 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -95.03 -80.21 1.49 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.69 -0.767 . . . . 73.51 112.472 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 2.6 mtp85 -115.58 -79.01 0.58 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.882 0.373 . . . . 75.23 110.883 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.26 32.21 5.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 74.23 110.886 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 77.7 m -121.32 75.58 32.34 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.555 0.693 . . . . 75.21 110.86 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.451 ' HB3' ' CZ2' ' A' ' 5' ' ' TRP . 53.6 Cg_endo -69.77 132.11 22.63 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.675 2.25 . . . . 75.44 112.333 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -120.46 27.52 8.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 75.52 110.902 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.551 ' N ' ' CD2' ' A' ' 12' ' ' PHE . 0.1 OUTLIER -123.76 26.54 7.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.446 . . . . 75.23 110.824 179.991 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 C-N-CA 120.771 -0.728 . . . . 74.2 112.475 -179.954 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 96.6 t . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.896 0.379 . . . . 74.12 111.146 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -120.85 -56.27 1.95 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.184 -0.462 . . . . 72.13 111.088 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 21.2 mtt180 -120.52 -74.17 0.62 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.258 -0.428 . . . . 74.41 110.876 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -117.85 2.01 17.44 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.706 -0.759 . . . . 63.35 112.49 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.449 ' CZ2' ' HB3' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -51.82 92.51 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.81 0.338 . . . . 71.21 110.921 -179.923 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -95.06 -80.19 1.49 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.754 -0.736 . . . . 71.15 112.461 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -115.61 -79.11 0.58 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.886 0.374 . . . . 72.42 110.841 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.21 32.25 5.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.162 -0.472 . . . . 73.03 110.866 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 61.9 m -121.31 75.52 32.22 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.63 0.729 . . . . 75.11 110.909 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.449 ' HB3' ' CZ2' ' A' ' 5' ' ' TRP . 54.4 Cg_endo -69.69 132.02 22.56 Favored 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.744 2.296 . . . . 71.02 112.361 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -120.46 27.59 8.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.254 -0.43 . . . . 75.21 110.911 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.55 ' N ' ' CD2' ' A' ' 12' ' ' PHE . 0.1 OUTLIER -123.8 26.12 7.78 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.231 -0.44 . . . . 75.02 110.875 179.951 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.262 0 C-N-CA 120.701 -0.761 . . . . 34.13 112.476 -179.967 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 96.5 t . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.86 0.362 . . . . 70.25 111.128 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -120.81 -56.29 1.95 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.137 -0.483 . . . . 71.21 111.083 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 1.9 mtt180 -120.55 -74.19 0.62 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.235 -0.439 . . . . 71.11 110.89 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -117.81 2.08 17.52 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.745 -0.74 . . . . 62.21 112.498 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.456 ' CZ2' ' HB3' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -51.91 92.49 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.851 0.358 . . . . 74.3 110.869 -179.893 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -94.96 -80.25 1.5 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.776 -0.726 . . . . 64.34 112.478 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 56.3 mtm180 -115.6 -79.01 0.58 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.919 0.39 . . . . 74.22 110.916 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.24 32.22 5.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.16 -0.473 . . . . 74.44 110.908 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 82.6 m -121.34 75.59 32.52 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.623 0.725 . . . . 61.01 110.912 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.456 ' HB3' ' CZ2' ' A' ' 5' ' ' TRP . 53.7 Cg_endo -69.78 132.05 22.49 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.719 2.279 . . . . 74.2 112.338 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -120.47 27.53 8.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 74.34 110.901 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.542 ' N ' ' CD2' ' A' ' 12' ' ' PHE . 0.1 OUTLIER -123.79 26.47 7.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.227 -0.442 . . . . 73.41 110.852 179.945 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.27 0 C-N-CA 120.714 -0.755 . . . . 73.14 112.465 -179.971 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 96.5 t . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.843 0.354 . . . . 72.42 111.183 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -120.82 -56.31 1.95 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.167 -0.47 . . . . 73.23 111.105 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 48.2 mtt180 -120.53 -74.21 0.62 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.45 . . . . 75.23 110.865 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -117.84 2.05 17.46 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.717 -0.754 . . . . 74.23 112.497 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.455 ' CZ2' ' HB3' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -51.88 92.53 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.838 0.351 . . . . 75.23 110.898 -179.907 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -95.0 -80.47 1.51 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.761 -0.733 . . . . 50.14 112.472 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.33 -79.0 0.58 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.838 0.352 . . . . 74.43 110.879 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.31 32.31 5.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.204 -0.453 . . . . 75.12 110.925 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.3 m -121.4 75.6 33.15 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.617 0.722 . . . . 64.31 110.878 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.455 ' HB3' ' CZ2' ' A' ' 5' ' ' TRP . 54.0 Cg_endo -69.72 132.1 22.68 Favored 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.682 2.255 . . . . 75.02 112.391 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -120.47 27.59 8.49 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.288 -0.414 . . . . 75.23 110.971 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.55 ' N ' ' CD1' ' A' ' 12' ' ' PHE . 0.1 OUTLIER -123.81 26.6 7.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 75.21 110.901 179.919 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.38 0 C-N-CA 120.753 -0.737 . . . . 73.45 112.52 -179.984 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 96.5 t . . . . . 0 N--CA 1.457 -0.079 0 CA-C-O 120.862 0.363 . . . . 72.44 111.14 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -120.81 -56.27 1.95 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.466 . . . . 75.02 111.082 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -120.5 -74.2 0.62 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.254 -0.43 . . . . 75.32 110.895 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -117.86 2.02 17.42 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.725 -0.75 . . . . 53.4 112.532 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.447 ' CD1' ' CE2' ' A' ' 12' ' ' PHE . 0.0 OUTLIER -51.83 92.5 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.792 0.329 . . . . 63.02 110.902 -179.913 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -94.98 -80.29 1.5 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.754 -0.736 . . . . 60.43 112.52 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 11.2 mtt180 -115.57 -78.98 0.58 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.891 0.377 . . . . 75.51 110.81 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.31 32.26 5.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.451 . . . . 74.31 110.917 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 84.2 m -121.36 75.61 32.79 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.638 0.732 . . . . 74.15 110.894 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.443 ' HB3' ' CZ2' ' A' ' 5' ' ' TRP . 53.5 Cg_endo -69.81 132.1 22.55 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.692 2.262 . . . . 74.45 112.327 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -120.43 27.54 8.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 73.22 110.919 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.544 ' N ' ' CD2' ' A' ' 12' ' ' PHE . 0.1 OUTLIER -123.77 26.09 7.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 72.2 110.868 179.967 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 C-N-CA 120.712 -0.756 . . . . 64.14 112.509 -179.973 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 96.1 t . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.809 0.338 . . . . 64.14 111.12 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -120.76 -56.22 1.96 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.24 -0.436 . . . . 73.42 111.124 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 5.3 mtt180 -120.57 -73.96 0.63 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.459 . . . . 73.21 110.895 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -118.19 2.05 16.64 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.742 -0.742 . . . . 62.22 112.494 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.46 ' CZ2' ' HB3' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -51.86 91.97 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.813 0.34 . . . . 75.14 110.969 -179.936 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -93.71 -81.15 1.5 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.738 -0.744 . . . . 75.44 112.516 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.72 -77.83 0.57 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.839 0.352 . . . . 75.52 110.875 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.51 31.86 5.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 73.25 110.867 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 43.0 m -121.3 75.35 31.92 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.598 0.713 . . . . 73.14 110.864 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.46 ' HB3' ' CZ2' ' A' ' 5' ' ' TRP . 54.0 Cg_endo -69.8 132.36 23.11 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.645 2.23 . . . . 74.32 112.336 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -120.57 27.55 8.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.204 -0.453 . . . . 74.51 110.884 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.552 ' N ' ' CD1' ' A' ' 12' ' ' PHE . 0.1 OUTLIER -123.81 26.66 7.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 72.21 110.87 179.927 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.299 0 C-N-CA 120.752 -0.737 . . . . 72.21 112.481 -179.973 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 96.0 t . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.868 0.366 . . . . 72.43 111.108 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -120.74 -56.26 1.96 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 75.24 111.072 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.49 -74.06 0.62 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.19 -0.459 . . . . 74.32 110.874 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -118.16 2.18 16.67 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.717 -0.754 . . . . 72.11 112.47 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.459 ' CZ2' ' HB3' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -51.93 92.06 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.807 0.337 . . . . 72.35 110.925 -179.942 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -93.8 -81.29 1.5 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.72 -0.752 . . . . 61.42 112.493 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 2.9 ttt180 -115.44 -77.84 0.57 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.872 0.368 . . . . 74.23 110.914 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.61 31.89 5.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 73.32 110.879 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 2.6 m -121.27 75.38 31.64 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.62 0.724 . . . . 71.03 110.894 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.459 ' HB3' ' CZ2' ' A' ' 5' ' ' TRP . 53.7 Cg_endo -69.75 132.27 23.0 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.691 2.261 . . . . 73.3 112.324 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -120.52 27.58 8.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 75.02 110.934 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.552 ' N ' ' CD2' ' A' ' 12' ' ' PHE . 0.1 OUTLIER -123.78 26.19 7.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 72.12 110.902 179.942 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.34 0 C-N-CA 120.795 -0.717 . . . . 63.42 112.49 -179.934 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 96.5 t . . . . . 0 C--O 1.23 0.06 0 CA-C-O 120.849 0.356 . . . . 75.42 111.12 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -120.71 -56.41 1.96 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.168 -0.469 . . . . 75.14 111.104 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -120.47 -74.38 0.61 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.216 -0.447 . . . . 74.42 110.871 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -117.56 2.15 18.11 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.753 -0.737 . . . . 62.33 112.54 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.462 ' CZ2' ' HB3' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -51.75 92.9 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.829 0.347 . . . . 74.32 110.908 -179.923 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -95.15 -77.49 1.37 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.782 -0.723 . . . . 62.12 112.45 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.33 -77.57 0.58 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.939 0.399 . . . . 72.35 110.903 -179.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.95 31.36 5.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.179 -0.464 . . . . 75.13 110.881 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 57.2 m -121.13 74.85 29.41 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.608 0.718 . . . . 72.54 110.902 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.462 ' HB3' ' CZ2' ' A' ' 5' ' ' TRP . 53.6 Cg_endo -69.74 131.89 22.23 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.695 2.263 . . . . 71.1 112.346 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -120.6 27.22 8.67 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.216 -0.447 . . . . 74.43 110.958 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.547 ' N ' ' CD1' ' A' ' 12' ' ' PHE . 0.1 OUTLIER -123.84 26.37 7.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.18 -0.464 . . . . 75.13 110.889 179.935 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.34 0 C-N-CA 120.715 -0.755 . . . . 73.55 112.472 -179.989 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 97.0 t . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.812 0.339 . . . . 73.23 111.14 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -120.74 -56.39 1.95 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 74.34 111.087 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 3.0 mtp180 -120.46 -74.49 0.61 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.225 -0.443 . . . . 73.23 110.867 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -117.5 2.13 18.26 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.723 -0.751 . . . . 65.1 112.457 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.452 ' CD1' ' CE1' ' A' ' 12' ' ' PHE . 0.0 OUTLIER -51.75 93.06 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.802 0.335 . . . . 75.32 110.924 -179.938 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -95.68 -77.46 1.37 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.784 -0.722 . . . . 70.3 112.489 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -119.76 -78.17 0.59 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.92 0.391 . . . . 73.13 110.914 -179.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.85 31.74 5.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.169 -0.469 . . . . 62.3 110.907 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 62.1 m -121.31 75.05 31.61 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.622 0.725 . . . . 71.33 110.9 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.451 ' HB3' ' CZ2' ' A' ' 5' ' ' TRP . 53.7 Cg_endo -69.79 131.82 21.99 Favored 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.694 2.263 . . . . 61.33 112.309 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -120.63 27.24 8.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 74.41 110.879 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.548 ' N ' ' CD1' ' A' ' 12' ' ' PHE . 0.1 OUTLIER -123.87 26.61 7.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.214 -0.448 . . . . 74.45 110.894 179.914 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.262 0 C-N-CA 120.685 -0.769 . . . . 54.02 112.46 -179.99 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 92.1 t . . . . . 0 C--O 1.23 0.058 0 CA-C-O 120.82 0.343 . . . . 73.54 111.084 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -120.49 -58.5 1.84 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 74.33 111.115 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.38 -70.79 0.76 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.215 -0.448 . . . . 73.04 110.865 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.44 ' O ' ' N ' ' A' ' 6' ' ' GLY . . . -120.61 5.28 11.75 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.74 -0.743 . . . . 73.01 112.488 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.498 ' CZ2' ' HB3' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -58.87 82.38 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.803 0.335 . . . . 74.01 110.879 -179.899 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' A' ' 4' ' ' GLY . . . -84.97 -95.69 0.71 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.731 -0.747 . . . . 73.22 112.446 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 15.1 mtp180 -99.07 -79.09 0.49 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.863 0.363 . . . . 75.51 110.869 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.39 33.16 5.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.205 -0.452 . . . . 75.41 110.887 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 86.6 m -120.48 72.28 19.94 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.609 0.719 . . . . 74.42 110.873 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.498 ' HB3' ' CZ2' ' A' ' 5' ' ' TRP . 54.0 Cg_endo -69.8 136.68 33.51 Favored 'Trans proline' 0 N--CA 1.465 -0.171 0 C-N-CA 122.725 2.283 . . . . 73.3 112.365 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -121.41 29.26 7.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.24 -0.436 . . . . 74.31 110.93 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.532 ' N ' ' CD2' ' A' ' 12' ' ' PHE . 0.2 OUTLIER -122.1 27.58 7.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 75.43 110.907 179.944 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.344 0 C-N-CA 120.741 -0.742 . . . . 62.23 112.528 -179.966 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 93.1 t . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.783 0.325 . . . . 74.54 111.11 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -120.51 -58.32 1.85 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.466 . . . . 74.2 111.071 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.36 -70.96 0.75 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.232 -0.44 . . . . 72.32 110.872 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.44 ' O ' ' N ' ' A' ' 6' ' ' GLY . . . -120.62 5.46 11.7 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.714 -0.755 . . . . 74.21 112.461 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.488 ' CZ2' ' HB3' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -58.96 82.31 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.799 0.333 . . . . 71.1 110.958 -179.929 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' A' ' 4' ' ' GLY . . . -85.2 -96.54 0.72 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.749 -0.738 . . . . 75.43 112.518 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.49 -79.68 0.46 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.869 0.366 . . . . 71.53 110.883 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.49 33.9 4.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.176 -0.466 . . . . 71.31 110.909 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 46.0 m -120.91 72.44 22.72 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.626 0.727 . . . . 73.41 110.861 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.488 ' HB3' ' CZ2' ' A' ' 5' ' ' TRP . 53.9 Cg_endo -69.76 136.54 33.26 Favored 'Trans proline' 0 N--CA 1.465 -0.198 0 C-N-CA 122.724 2.282 . . . . 75.4 112.383 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -121.37 29.36 7.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.221 -0.445 . . . . 72.52 110.942 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.543 ' N ' ' CD2' ' A' ' 12' ' ' PHE . 0.2 OUTLIER -122.19 27.14 8.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.167 -0.469 . . . . 72.44 110.874 179.923 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.266 0 C-N-CA 120.763 -0.732 . . . . 71.44 112.47 -179.98 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.471 HG23 ' HB3' ' A' ' 5' ' ' TRP . 96.4 t . . . . . 0 C--O 1.23 0.046 0 CA-C-O 120.849 0.357 . . . . 73.51 111.136 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.663 ' HB3' ' CE1' ' A' ' 12' ' ' PHE . . . -120.82 -56.3 1.95 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.166 -0.47 . . . . 74.31 111.079 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 3.0 mtt180 -120.5 -74.2 0.62 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.456 . . . . 71.33 110.882 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.67 ' C ' HD21 ' A' ' 11' ' ' LEU . . . -117.82 1.93 17.53 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.774 -0.727 . . . . 63.14 112.489 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.471 ' HB3' HG23 ' A' ' 1' ' ' VAL . 0.0 OUTLIER -51.66 92.5 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.751 0.31 . . . . 75.41 110.951 -179.967 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -94.91 -79.51 1.46 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.723 -0.751 . . . . 62.15 112.487 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 12.9 mtm-85 -116.75 -78.67 0.58 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.83 0.348 . . . . 72.13 110.848 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.17 31.74 5.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.171 -0.468 . . . . 74.42 110.908 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.8 m -121.04 75.45 29.37 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.595 0.712 . . . . 64.43 110.891 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.446 ' HB3' ' CZ2' ' A' ' 5' ' ' TRP . 54.0 Cg_endo -69.76 132.09 22.6 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.696 2.264 . . . . 75.34 112.347 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.67 HD21 ' C ' ' A' ' 4' ' ' GLY . 0.3 OUTLIER -120.53 27.55 8.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 73.41 110.916 179.959 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.663 ' CE1' ' HB3' ' A' ' 2' ' ' ALA . 0.1 OUTLIER -123.73 26.78 7.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 74.22 110.938 179.907 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.265 0 C-N-CA 120.686 -0.768 . . . . 52.14 112.495 -179.964 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.478 HG23 ' HB3' ' A' ' 5' ' ' TRP . 96.5 t . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.845 0.355 . . . . 71.42 111.113 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.66 ' HB3' ' CE2' ' A' ' 12' ' ' PHE . . . -120.77 -56.32 1.95 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.456 . . . . 40.21 111.127 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 4.4 mtt180 -120.54 -74.13 0.62 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.464 . . . . 73.11 110.875 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.686 ' C ' HD21 ' A' ' 11' ' ' LEU . . . -117.89 2.07 17.35 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.735 -0.745 . . . . 63.43 112.48 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.478 ' HB3' HG23 ' A' ' 1' ' ' VAL . 0.0 OUTLIER -51.86 92.44 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.796 0.331 . . . . 73.02 110.927 -179.934 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -95.02 -80.19 1.49 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.727 -0.749 . . . . 73.01 112.509 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.57 -79.04 0.58 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.869 0.366 . . . . 73.44 110.921 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.25 32.31 5.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.464 . . . . 71.25 110.853 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 65.1 m -121.36 75.56 32.78 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.554 0.693 . . . . 64.14 110.833 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.45 ' HB3' ' CZ2' ' A' ' 5' ' ' TRP . 53.7 Cg_endo -69.75 132.15 22.74 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.637 2.225 . . . . 73.21 112.324 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.686 HD21 ' C ' ' A' ' 4' ' ' GLY . 0.3 OUTLIER -120.53 27.59 8.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.185 -0.461 . . . . 63.44 110.922 179.93 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.66 ' CE2' ' HB3' ' A' ' 2' ' ' ALA . 0.1 OUTLIER -123.79 25.99 7.84 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.162 -0.472 . . . . 65.34 110.913 179.897 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.28 0 C-N-CA 120.756 -0.735 . . . . 73.41 112.44 -179.95 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.48 HG23 ' HB3' ' A' ' 5' ' ' TRP . 96.7 t . . . . . 0 N--CA 1.458 -0.053 0 CA-C-O 120.856 0.36 . . . . 75.43 111.147 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.657 ' HB3' ' CE2' ' A' ' 12' ' ' PHE . . . -120.79 -56.26 1.96 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.136 -0.484 . . . . 43.32 111.096 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 4.8 mtt85 -120.58 -74.16 0.62 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.249 -0.432 . . . . 63.42 110.893 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.684 ' C ' HD21 ' A' ' 11' ' ' LEU . . . -117.85 2.03 17.44 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.765 -0.731 . . . . 71.42 112.492 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.48 ' HB3' HG23 ' A' ' 1' ' ' VAL . 0.0 OUTLIER -51.87 92.51 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.8 0.333 . . . . 75.51 110.903 -179.904 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -95.01 -80.24 1.5 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.738 -0.744 . . . . 72.45 112.5 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 11.2 mtp85 -115.55 -79.08 0.58 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.896 0.379 . . . . 75.02 110.874 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.2 32.28 5.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.161 -0.472 . . . . 65.32 110.897 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 82.8 m -121.36 75.57 32.71 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.603 0.716 . . . . 53.51 110.879 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.451 ' HB3' ' CZ2' ' A' ' 5' ' ' TRP . 53.8 Cg_endo -69.74 132.09 22.63 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.695 2.263 . . . . 74.33 112.371 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.684 HD21 ' C ' ' A' ' 4' ' ' GLY . 0.3 OUTLIER -120.48 27.54 8.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.214 -0.448 . . . . 74.51 110.899 179.987 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.657 ' CE2' ' HB3' ' A' ' 2' ' ' ALA . 0.1 OUTLIER -123.81 26.07 7.8 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.209 -0.45 . . . . 74.24 110.896 179.957 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.319 0 C-N-CA 120.751 -0.737 . . . . 63.52 112.459 -179.976 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.479 HG23 ' HB3' ' A' ' 5' ' ' TRP . 96.6 t . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.934 0.397 . . . . 73.24 111.15 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.65 ' HB3' ' CE2' ' A' ' 12' ' ' PHE . . . -120.85 -56.27 1.95 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.11 -0.495 . . . . 64.44 111.052 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 1.9 mtt180 -120.55 -74.2 0.62 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 75.31 110.869 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.687 ' C ' HD21 ' A' ' 11' ' ' LEU . . . -117.84 2.04 17.45 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.72 -0.752 . . . . 73.51 112.438 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.479 ' HB3' HG23 ' A' ' 1' ' ' VAL . 0.0 OUTLIER -51.83 92.48 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.823 0.344 . . . . 73.13 110.904 -179.903 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -95.04 -80.3 1.5 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.764 -0.731 . . . . 30.45 112.483 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.3 mtp180 -115.47 -79.08 0.58 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.907 0.384 . . . . 75.34 110.864 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.2 32.24 5.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 72.43 110.877 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 35.8 m -121.32 75.57 32.32 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.605 0.717 . . . . 64.14 110.901 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.447 ' HB3' ' CZ2' ' A' ' 5' ' ' TRP . 53.3 Cg_endo -69.79 132.12 22.61 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.707 2.272 . . . . 74.04 112.306 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.687 HD21 ' C ' ' A' ' 4' ' ' GLY . 0.3 OUTLIER -120.48 27.52 8.52 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.184 -0.462 . . . . 64.24 110.909 179.97 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.65 ' CE2' ' HB3' ' A' ' 2' ' ' ALA . 0.1 OUTLIER -123.79 26.77 7.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.451 . . . . 71.54 110.912 179.915 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 C-N-CA 120.72 -0.753 . . . . 62.34 112.507 -179.973 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.484 HG23 ' HB3' ' A' ' 5' ' ' TRP . 96.6 t . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.852 0.358 . . . . 73.1 111.145 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.652 ' HB3' ' CE2' ' A' ' 12' ' ' PHE . . . -120.77 -56.26 1.96 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.204 -0.453 . . . . 72.41 111.099 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -120.51 -74.25 0.62 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.217 -0.447 . . . . 73.15 110.852 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.685 ' C ' HD21 ' A' ' 11' ' ' LEU . . . -117.82 2.02 17.51 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.75 -0.738 . . . . 50.44 112.443 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.484 ' HB3' HG23 ' A' ' 1' ' ' VAL . 0.0 OUTLIER -51.86 92.42 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.783 0.325 . . . . 74.41 110.947 -179.917 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -94.98 -80.23 1.5 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.703 -0.761 . . . . 71.04 112.502 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 4.0 mtt85 -115.52 -79.05 0.58 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.924 0.392 . . . . 61.41 110.887 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.22 32.22 5.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 72.02 110.922 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 3.2 m -121.31 75.6 32.31 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.575 0.702 . . . . 71.25 110.87 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.443 ' HB3' ' CZ2' ' A' ' 5' ' ' TRP . 53.5 Cg_endo -69.78 132.17 22.74 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.692 2.262 . . . . 52.04 112.309 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.685 HD21 ' C ' ' A' ' 4' ' ' GLY . 0.3 OUTLIER -120.53 27.5 8.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.234 -0.439 . . . . 72.34 110.901 179.968 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.652 ' CE2' ' HB3' ' A' ' 2' ' ' ALA . 0.1 OUTLIER -123.76 26.22 7.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 63.42 110.911 179.943 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.318 0 C-N-CA 120.721 -0.752 . . . . 70.42 112.497 -179.941 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.474 HG23 ' HB3' ' A' ' 5' ' ' TRP . 96.6 t . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.811 0.338 . . . . 74.32 111.108 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.667 ' HB3' ' CE2' ' A' ' 12' ' ' PHE . . . -120.85 -56.33 1.95 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.133 -0.485 . . . . 70.41 111.108 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -120.49 -74.15 0.62 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 73.35 110.893 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.673 ' C ' HD21 ' A' ' 11' ' ' LEU . . . -117.96 2.11 17.17 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.712 -0.756 . . . . 70.45 112.45 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.474 ' HB3' HG23 ' A' ' 1' ' ' VAL . 0.0 OUTLIER -51.84 92.52 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.853 0.359 . . . . 54.15 110.938 -179.961 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -95.05 -80.21 1.5 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.762 -0.732 . . . . 74.55 112.497 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 44.7 mtt180 -115.62 -79.05 0.58 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.847 0.356 . . . . 71.33 110.873 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.25 32.25 5.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 74.32 110.89 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 72.4 m -121.33 75.57 32.4 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.625 0.726 . . . . 43.43 110.881 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.441 ' HB3' ' CZ2' ' A' ' 5' ' ' TRP . 53.7 Cg_endo -69.71 132.06 22.62 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.71 2.274 . . . . 73.42 112.365 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.673 HD21 ' C ' ' A' ' 4' ' ' GLY . 0.3 OUTLIER -120.48 27.57 8.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.282 -0.417 . . . . 63.5 110.897 179.97 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.667 ' CE2' ' HB3' ' A' ' 2' ' ' ALA . 0.1 OUTLIER -123.79 26.18 7.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 74.4 110.843 179.963 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.283 0 C-N-CA 120.735 -0.745 . . . . 24.41 112.446 -179.917 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.474 HG23 ' HB3' ' A' ' 5' ' ' TRP . 96.4 t . . . . . 0 N--CA 1.457 -0.091 0 CA-C-O 120.878 0.371 . . . . 72.11 111.136 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.66 ' HB3' ' CE1' ' A' ' 12' ' ' PHE . . . -120.8 -56.24 1.96 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.124 -0.489 . . . . 72.23 111.096 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 13.2 mtt85 -120.5 -74.3 0.62 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 73.3 110.861 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.684 ' C ' HD21 ' A' ' 11' ' ' LEU . . . -117.75 1.94 17.69 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.764 -0.731 . . . . 74.53 112.487 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.474 ' HB3' HG23 ' A' ' 1' ' ' VAL . 0.0 OUTLIER -51.83 92.44 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.795 0.331 . . . . 75.33 110.914 -179.877 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -94.99 -80.27 1.5 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.718 -0.753 . . . . 71.24 112.496 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 5.0 mtp180 -115.48 -79.05 0.58 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.863 0.363 . . . . 74.12 110.9 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.23 32.26 5.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.469 . . . . 75.22 110.875 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 33.9 m -121.38 75.58 32.95 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.621 0.724 . . . . 64.05 110.926 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.447 ' HB3' ' CZ2' ' A' ' 5' ' ' TRP . 54.0 Cg_endo -69.71 132.18 22.85 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.638 2.225 . . . . 71.31 112.359 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.684 HD21 ' C ' ' A' ' 4' ' ' GLY . 0.3 OUTLIER -120.52 27.53 8.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.218 -0.446 . . . . 73.33 110.906 179.979 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.66 ' CE1' ' HB3' ' A' ' 2' ' ' ALA . 0.1 OUTLIER -123.78 26.77 7.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 73.31 110.862 179.966 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.309 0 C-N-CA 120.706 -0.759 . . . . 52.12 112.464 -179.959 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.473 HG23 ' HB3' ' A' ' 5' ' ' TRP . 96.6 t . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.84 0.352 . . . . 63.44 111.143 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.662 ' HB3' ' CE1' ' A' ' 12' ' ' PHE . . . -120.77 -56.28 1.96 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 60.15 111.147 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -120.52 -74.21 0.62 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.19 -0.459 . . . . 72.12 110.882 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.674 ' C ' HD21 ' A' ' 11' ' ' LEU . . . -117.79 2.01 17.6 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.765 -0.731 . . . . 62.42 112.468 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.473 ' HB3' HG23 ' A' ' 1' ' ' VAL . 0.0 OUTLIER -51.88 92.45 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.813 0.34 . . . . 74.21 110.894 -179.894 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -94.98 -80.2 1.49 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.726 -0.749 . . . . 63.32 112.494 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 8.6 mtt180 -115.56 -79.06 0.58 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.916 0.389 . . . . 74.14 110.898 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.21 32.24 5.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.116 -0.493 . . . . 74.24 110.924 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 90.4 m -121.33 75.57 32.39 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.63 0.729 . . . . 72.03 110.88 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.441 ' HB3' ' CZ2' ' A' ' 5' ' ' TRP . 54.6 Cg_endo -69.7 132.06 22.63 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.736 2.291 . . . . 73.44 112.366 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.674 HD21 ' C ' ' A' ' 4' ' ' GLY . 0.3 OUTLIER -120.49 27.59 8.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.23 -0.441 . . . . 54.41 110.97 179.93 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.662 ' CE1' ' HB3' ' A' ' 2' ' ' ALA . 0.1 OUTLIER -123.83 26.33 7.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.47 . . . . 73.03 110.876 179.953 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 C-N-CA 120.726 -0.75 . . . . 62.01 112.454 -179.964 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.478 HG23 ' HB3' ' A' ' 5' ' ' TRP . 96.4 t . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.813 0.339 . . . . 72.2 111.087 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.659 ' HB3' ' CE1' ' A' ' 12' ' ' PHE . . . -120.78 -56.3 1.95 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.459 . . . . 74.23 111.092 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 19.7 mtt180 -120.56 -74.18 0.62 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.238 -0.437 . . . . 73.33 110.904 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.684 ' C ' HD21 ' A' ' 11' ' ' LEU . . . -117.87 2.08 17.39 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.704 -0.76 . . . . 61.21 112.461 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.478 ' HB3' HG23 ' A' ' 1' ' ' VAL . 0.0 OUTLIER -51.87 92.43 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.798 0.333 . . . . 74.42 110.92 -179.921 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -95.01 -80.24 1.5 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.758 -0.734 . . . . 44.33 112.486 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 3.1 mtt180 -115.51 -79.08 0.58 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.84 0.353 . . . . 73.1 110.883 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.21 32.25 5.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.449 . . . . 71.43 110.874 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.6 m -121.34 75.64 32.58 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.629 0.728 . . . . 64.13 110.901 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.441 ' HB3' ' CZ2' ' A' ' 5' ' ' TRP . 54.0 Cg_endo -69.77 132.11 22.62 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.648 2.232 . . . . 64.51 112.349 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.684 HD21 ' C ' ' A' ' 4' ' ' GLY . 0.3 OUTLIER -120.44 27.46 8.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.231 -0.44 . . . . 71.14 110.955 179.971 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.659 ' CE1' ' HB3' ' A' ' 2' ' ' ALA . 0.1 OUTLIER -123.79 26.77 7.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 73.54 110.893 179.946 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.318 0 C-N-CA 120.748 -0.739 . . . . 33.32 112.497 -179.984 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.477 HG23 ' HB3' ' A' ' 5' ' ' TRP . 96.4 t . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.84 0.352 . . . . 73.43 111.076 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.651 ' HB3' ' CE1' ' A' ' 12' ' ' PHE . . . -120.83 -56.2 1.96 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.194 -0.457 . . . . 74.05 111.095 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 12.7 mtp180 -120.6 -74.17 0.62 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.45 . . . . 75.0 110.838 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.685 ' C ' HD21 ' A' ' 11' ' ' LEU . . . -117.83 2.04 17.49 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.777 -0.725 . . . . 61.14 112.491 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.477 ' HB3' HG23 ' A' ' 1' ' ' VAL . 0.0 OUTLIER -51.93 92.54 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.841 0.353 . . . . 74.34 110.917 -179.874 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -95.03 -80.21 1.49 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.69 -0.767 . . . . 73.51 112.472 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 2.6 mtp85 -115.58 -79.01 0.58 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.882 0.373 . . . . 71.22 110.883 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.26 32.21 5.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 74.23 110.886 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 77.7 m -121.32 75.58 32.34 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.555 0.693 . . . . 74.32 110.86 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.447 ' HB3' ' CZ2' ' A' ' 5' ' ' TRP . 53.6 Cg_endo -69.77 132.11 22.63 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.675 2.25 . . . . 75.44 112.333 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.685 HD21 ' C ' ' A' ' 4' ' ' GLY . 0.3 OUTLIER -120.46 27.52 8.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 75.52 110.902 179.957 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.651 ' CE1' ' HB3' ' A' ' 2' ' ' ALA . 0.1 OUTLIER -123.76 26.54 7.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.446 . . . . 72.54 110.824 179.991 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 C-N-CA 120.771 -0.728 . . . . 64.32 112.475 -179.954 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.478 HG23 ' HB3' ' A' ' 5' ' ' TRP . 96.6 t . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.896 0.379 . . . . 72.2 111.146 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.658 ' HB3' ' CE1' ' A' ' 12' ' ' PHE . . . -120.85 -56.27 1.95 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.184 -0.462 . . . . 72.13 111.088 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 21.2 mtt180 -120.52 -74.17 0.62 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.258 -0.428 . . . . 74.41 110.876 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.684 ' C ' HD21 ' A' ' 11' ' ' LEU . . . -117.85 2.01 17.44 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.706 -0.759 . . . . 14.53 112.49 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.478 ' HB3' HG23 ' A' ' 1' ' ' VAL . 0.0 OUTLIER -51.82 92.51 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.81 0.338 . . . . 71.21 110.921 -179.923 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -95.06 -80.19 1.49 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.754 -0.736 . . . . 71.15 112.461 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -115.61 -79.11 0.58 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.886 0.374 . . . . 72.42 110.841 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.21 32.25 5.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.162 -0.472 . . . . 73.03 110.866 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 61.9 m -121.31 75.52 32.22 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.63 0.729 . . . . 73.24 110.909 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.447 ' HB3' ' CZ2' ' A' ' 5' ' ' TRP . 54.4 Cg_endo -69.69 132.02 22.56 Favored 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.744 2.296 . . . . 70.31 112.361 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.684 HD21 ' C ' ' A' ' 4' ' ' GLY . 0.3 OUTLIER -120.46 27.59 8.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.254 -0.43 . . . . 75.21 110.911 179.978 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.658 ' CE1' ' HB3' ' A' ' 2' ' ' ALA . 0.1 OUTLIER -123.8 26.12 7.78 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.231 -0.44 . . . . 55.45 110.875 179.951 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.262 0 C-N-CA 120.701 -0.761 . . . . 34.13 112.476 -179.967 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.479 HG23 ' HB3' ' A' ' 5' ' ' TRP . 96.5 t . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.86 0.362 . . . . 63.01 111.128 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.656 ' HB3' ' CE1' ' A' ' 12' ' ' PHE . . . -120.81 -56.29 1.95 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.137 -0.483 . . . . 71.21 111.083 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 1.9 mtt180 -120.55 -74.19 0.62 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.235 -0.439 . . . . 62.25 110.89 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.678 ' C ' HD21 ' A' ' 11' ' ' LEU . . . -117.81 2.08 17.52 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.745 -0.74 . . . . 62.21 112.498 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.479 ' HB3' HG23 ' A' ' 1' ' ' VAL . 0.0 OUTLIER -51.91 92.49 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.851 0.358 . . . . 74.3 110.869 -179.893 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -94.96 -80.25 1.5 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.776 -0.726 . . . . 64.34 112.478 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 56.3 mtm180 -115.6 -79.01 0.58 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.919 0.39 . . . . 73.33 110.916 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.24 32.22 5.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.16 -0.473 . . . . 74.44 110.908 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 82.6 m -121.34 75.59 32.52 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.623 0.725 . . . . 61.01 110.912 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.448 ' HB3' ' CZ2' ' A' ' 5' ' ' TRP . 53.7 Cg_endo -69.78 132.05 22.49 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.719 2.279 . . . . 72.34 112.338 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.678 HD21 ' C ' ' A' ' 4' ' ' GLY . 0.3 OUTLIER -120.47 27.53 8.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 74.34 110.901 179.991 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.656 ' CE1' ' HB3' ' A' ' 2' ' ' ALA . 0.1 OUTLIER -123.79 26.47 7.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.227 -0.442 . . . . 73.41 110.852 179.945 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.27 0 C-N-CA 120.714 -0.755 . . . . 73.14 112.465 -179.971 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.484 HG23 ' HB3' ' A' ' 5' ' ' TRP . 96.5 t . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.843 0.354 . . . . 72.42 111.183 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.662 ' HB3' ' CE2' ' A' ' 12' ' ' PHE . . . -120.82 -56.31 1.95 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.167 -0.47 . . . . 73.23 111.105 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 48.2 mtt180 -120.53 -74.21 0.62 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.45 . . . . 75.23 110.865 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.672 ' C ' HD21 ' A' ' 11' ' ' LEU . . . -117.84 2.05 17.46 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.717 -0.754 . . . . 74.23 112.497 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.484 ' HB3' HG23 ' A' ' 1' ' ' VAL . 0.0 OUTLIER -51.88 92.53 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.838 0.351 . . . . 71.11 110.898 -179.907 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -95.0 -80.47 1.51 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.761 -0.733 . . . . 50.14 112.472 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.33 -79.0 0.58 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.838 0.352 . . . . 74.43 110.879 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.31 32.31 5.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.204 -0.453 . . . . 72.13 110.925 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.3 m -121.4 75.6 33.15 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.617 0.722 . . . . 54.11 110.878 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.452 ' HB3' ' CZ2' ' A' ' 5' ' ' TRP . 54.0 Cg_endo -69.72 132.1 22.68 Favored 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.682 2.255 . . . . 65.35 112.391 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.672 HD21 ' C ' ' A' ' 4' ' ' GLY . 0.3 OUTLIER -120.47 27.59 8.49 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.288 -0.414 . . . . 75.23 110.971 179.948 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.662 ' CE2' ' HB3' ' A' ' 2' ' ' ALA . 0.1 OUTLIER -123.81 26.6 7.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 75.21 110.901 179.919 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.38 0 C-N-CA 120.753 -0.737 . . . . 73.45 112.52 -179.984 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.48 HG23 ' HB3' ' A' ' 5' ' ' TRP . 96.5 t . . . . . 0 N--CA 1.457 -0.079 0 CA-C-O 120.862 0.363 . . . . 52.43 111.14 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.66 ' HB3' ' CE1' ' A' ' 12' ' ' PHE . . . -120.81 -56.27 1.95 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.466 . . . . 75.02 111.082 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -120.5 -74.2 0.62 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.254 -0.43 . . . . 75.32 110.895 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.679 ' C ' HD21 ' A' ' 11' ' ' LEU . . . -117.86 2.02 17.42 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.725 -0.75 . . . . 51.0 112.532 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.48 ' HB3' HG23 ' A' ' 1' ' ' VAL . 0.0 OUTLIER -51.83 92.5 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.792 0.329 . . . . 63.02 110.902 -179.913 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -94.98 -80.29 1.5 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.754 -0.736 . . . . 60.43 112.52 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 11.2 mtt180 -115.57 -78.98 0.58 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.891 0.377 . . . . 75.51 110.81 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.31 32.26 5.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.451 . . . . 74.31 110.917 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 84.2 m -121.36 75.61 32.79 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.638 0.732 . . . . 60.32 110.894 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.442 ' HB3' ' CZ2' ' A' ' 5' ' ' TRP . 53.5 Cg_endo -69.81 132.1 22.55 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.692 2.262 . . . . 64.43 112.327 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.679 HD21 ' C ' ' A' ' 4' ' ' GLY . 0.3 OUTLIER -120.43 27.54 8.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 64.32 110.919 179.969 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.66 ' CE1' ' HB3' ' A' ' 2' ' ' ALA . 0.1 OUTLIER -123.77 26.09 7.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 70.24 110.868 179.967 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 C-N-CA 120.712 -0.756 . . . . 60.14 112.509 -179.973 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.487 HG23 ' HB3' ' A' ' 5' ' ' TRP . 96.1 t . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.809 0.338 . . . . 64.14 111.12 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.643 ' HB3' ' CE2' ' A' ' 12' ' ' PHE . . . -120.76 -56.22 1.96 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.24 -0.436 . . . . 73.42 111.124 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 5.3 mtt180 -120.57 -73.96 0.63 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.459 . . . . 73.21 110.895 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.686 ' C ' HD21 ' A' ' 11' ' ' LEU . . . -118.19 2.05 16.64 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.742 -0.742 . . . . 61.13 112.494 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.487 ' HB3' HG23 ' A' ' 1' ' ' VAL . 0.0 OUTLIER -51.86 91.97 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.813 0.34 . . . . 75.14 110.969 -179.936 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -93.71 -81.15 1.5 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.738 -0.744 . . . . 73.21 112.516 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.72 -77.83 0.57 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.839 0.352 . . . . 72.03 110.875 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.51 31.86 5.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 73.25 110.867 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 43.0 m -121.3 75.35 31.92 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.598 0.713 . . . . 73.14 110.864 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.458 ' HB3' ' CZ2' ' A' ' 5' ' ' TRP . 54.0 Cg_endo -69.8 132.36 23.11 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.645 2.23 . . . . 51.23 112.336 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.686 HD21 ' C ' ' A' ' 4' ' ' GLY . 0.3 OUTLIER -120.57 27.55 8.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.204 -0.453 . . . . 65.44 110.884 179.989 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.643 ' CE2' ' HB3' ' A' ' 2' ' ' ALA . 0.1 OUTLIER -123.81 26.66 7.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 61.23 110.87 179.927 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.299 0 C-N-CA 120.752 -0.737 . . . . 63.43 112.481 -179.973 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.487 HG23 ' HB3' ' A' ' 5' ' ' TRP . 96.0 t . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.868 0.366 . . . . 65.12 111.108 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.646 ' HB3' ' CE1' ' A' ' 12' ' ' PHE . . . -120.74 -56.26 1.96 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 60.01 111.072 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.49 -74.06 0.62 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.19 -0.459 . . . . 74.32 110.874 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.684 ' C ' HD21 ' A' ' 11' ' ' LEU . . . -118.16 2.18 16.67 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.717 -0.754 . . . . 72.11 112.47 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.487 ' HB3' HG23 ' A' ' 1' ' ' VAL . 0.0 OUTLIER -51.93 92.06 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.807 0.337 . . . . 65.5 110.925 -179.942 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -93.8 -81.29 1.5 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.72 -0.752 . . . . 61.42 112.493 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 2.9 ttt180 -115.44 -77.84 0.57 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.872 0.368 . . . . 73.41 110.914 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.61 31.89 5.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 73.32 110.879 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 2.6 m -121.27 75.38 31.64 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.62 0.724 . . . . 71.03 110.894 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.456 ' HB3' ' CZ2' ' A' ' 5' ' ' TRP . 53.7 Cg_endo -69.75 132.27 23.0 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.691 2.261 . . . . 62.12 112.324 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.684 HD21 ' C ' ' A' ' 4' ' ' GLY . 0.3 OUTLIER -120.52 27.58 8.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 74.32 110.934 179.946 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.646 ' CE1' ' HB3' ' A' ' 2' ' ' ALA . 0.1 OUTLIER -123.78 26.19 7.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 44.22 110.902 179.942 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.34 0 C-N-CA 120.795 -0.717 . . . . 63.42 112.49 -179.934 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.491 HG23 ' HB3' ' A' ' 5' ' ' TRP . 96.5 t . . . . . 0 C--O 1.23 0.06 0 CA-C-O 120.849 0.356 . . . . 63.21 111.12 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.657 ' HB3' ' CE2' ' A' ' 12' ' ' PHE . . . -120.71 -56.41 1.96 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.168 -0.469 . . . . 75.14 111.104 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -120.47 -74.38 0.61 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.216 -0.447 . . . . 62.43 110.871 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.675 ' C ' HD21 ' A' ' 11' ' ' LEU . . . -117.56 2.15 18.11 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.753 -0.737 . . . . 62.33 112.54 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.491 ' HB3' HG23 ' A' ' 1' ' ' VAL . 0.0 OUTLIER -51.75 92.9 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.829 0.347 . . . . 65.01 110.908 -179.923 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -95.15 -77.49 1.37 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.782 -0.723 . . . . 52.21 112.45 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.33 -77.57 0.58 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.939 0.399 . . . . 72.05 110.903 -179.856 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.95 31.36 5.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.179 -0.464 . . . . 71.32 110.881 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 57.2 m -121.13 74.85 29.41 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.608 0.718 . . . . 72.54 110.902 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.457 ' HB3' ' CZ2' ' A' ' 5' ' ' TRP . 53.6 Cg_endo -69.74 131.89 22.23 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.695 2.263 . . . . 71.1 112.346 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.675 HD21 ' C ' ' A' ' 4' ' ' GLY . 0.3 OUTLIER -120.6 27.22 8.67 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.216 -0.447 . . . . 74.43 110.958 179.942 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.657 ' CE2' ' HB3' ' A' ' 2' ' ' ALA . 0.1 OUTLIER -123.84 26.37 7.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.18 -0.464 . . . . 75.05 110.889 179.935 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.34 0 C-N-CA 120.715 -0.755 . . . . 73.55 112.472 -179.989 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.487 HG23 ' HB3' ' A' ' 5' ' ' TRP . 97.0 t . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.812 0.339 . . . . 73.23 111.14 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.671 ' HB3' ' CE2' ' A' ' 12' ' ' PHE . . . -120.74 -56.39 1.95 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 64.31 111.087 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 3.0 mtp180 -120.46 -74.49 0.61 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.225 -0.443 . . . . 73.23 110.867 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.664 ' C ' HD21 ' A' ' 11' ' ' LEU . . . -117.5 2.13 18.26 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.723 -0.751 . . . . 65.1 112.457 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.487 ' HB3' HG23 ' A' ' 1' ' ' VAL . 0.0 OUTLIER -51.75 93.06 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.802 0.335 . . . . 74.04 110.924 -179.938 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -95.68 -77.46 1.37 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.784 -0.722 . . . . 70.3 112.489 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -119.76 -78.17 0.59 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.92 0.391 . . . . 73.13 110.914 -179.866 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.85 31.74 5.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.169 -0.469 . . . . 51.42 110.907 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 62.1 m -121.31 75.05 31.61 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.622 0.725 . . . . 64.51 110.9 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.443 ' HB3' ' CZ2' ' A' ' 5' ' ' TRP . 53.7 Cg_endo -69.79 131.82 21.99 Favored 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.694 2.263 . . . . 61.33 112.309 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.664 HD21 ' C ' ' A' ' 4' ' ' GLY . 0.3 OUTLIER -120.63 27.24 8.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 74.41 110.879 179.976 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.671 ' CE2' ' HB3' ' A' ' 2' ' ' ALA . 0.1 OUTLIER -123.87 26.61 7.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.214 -0.448 . . . . 74.45 110.894 179.914 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.262 0 C-N-CA 120.685 -0.769 . . . . 42.22 112.46 -179.99 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 92.1 t . . . . . 0 C--O 1.23 0.058 0 CA-C-O 120.82 0.343 . . . . 71.21 111.084 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.547 ' HB3' ' CE1' ' A' ' 12' ' ' PHE . . . -120.49 -58.5 1.84 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 74.33 111.115 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.599 ' HD3' HD12 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -121.38 -70.79 0.76 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.215 -0.448 . . . . 62.33 110.865 -179.883 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.732 ' C ' HD21 ' A' ' 11' ' ' LEU . . . -120.61 5.28 11.75 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.74 -0.743 . . . . 73.01 112.488 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.494 ' CZ2' ' HB3' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -58.87 82.38 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.803 0.335 . . . . 74.01 110.879 -179.899 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' A' ' 4' ' ' GLY . . . -84.97 -95.69 0.71 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.731 -0.747 . . . . 73.22 112.446 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 15.1 mtp180 -99.07 -79.09 0.49 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.863 0.363 . . . . 62.23 110.869 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.39 33.16 5.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.205 -0.452 . . . . 75.41 110.887 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 86.6 m -120.48 72.28 19.94 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.609 0.719 . . . . 73.52 110.873 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.494 ' HB3' ' CZ2' ' A' ' 5' ' ' TRP . 54.0 Cg_endo -69.8 136.68 33.51 Favored 'Trans proline' 0 N--CA 1.465 -0.171 0 C-N-CA 122.725 2.283 . . . . 63.14 112.365 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.732 HD21 ' C ' ' A' ' 4' ' ' GLY . 0.2 OUTLIER -121.41 29.26 7.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.24 -0.436 . . . . 73.3 110.93 179.971 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.547 ' CE1' ' HB3' ' A' ' 2' ' ' ALA . 0.2 OUTLIER -122.1 27.58 7.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 64.04 110.907 179.944 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.344 0 C-N-CA 120.741 -0.742 . . . . 62.23 112.528 -179.966 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 93.1 t . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.783 0.325 . . . . 72.11 111.11 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.536 ' HB3' ' CE1' ' A' ' 12' ' ' PHE . . . -120.51 -58.32 1.85 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.466 . . . . 74.2 111.071 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.609 ' HD3' HD12 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -121.36 -70.96 0.75 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.232 -0.44 . . . . 72.32 110.872 -179.895 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.734 ' C ' HD21 ' A' ' 11' ' ' LEU . . . -120.62 5.46 11.7 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.714 -0.755 . . . . 65.01 112.461 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.487 ' CZ2' ' HB3' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -58.96 82.31 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.799 0.333 . . . . 71.1 110.958 -179.929 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' A' ' 4' ' ' GLY . . . -85.2 -96.54 0.72 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.749 -0.738 . . . . 75.43 112.518 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.49 -79.68 0.46 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.869 0.366 . . . . 62.55 110.883 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.49 33.9 4.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.176 -0.466 . . . . 70.43 110.909 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 46.0 m -120.91 72.44 22.72 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.626 0.727 . . . . 73.41 110.861 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.487 ' HB3' ' CZ2' ' A' ' 5' ' ' TRP . 53.9 Cg_endo -69.76 136.54 33.26 Favored 'Trans proline' 0 N--CA 1.465 -0.198 0 C-N-CA 122.724 2.282 . . . . 75.4 112.383 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.734 HD21 ' C ' ' A' ' 4' ' ' GLY . 0.2 OUTLIER -121.37 29.36 7.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.221 -0.445 . . . . 72.52 110.942 -179.995 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.543 ' N ' ' CD2' ' A' ' 12' ' ' PHE . 0.2 OUTLIER -122.19 27.14 8.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.167 -0.469 . . . . 64.21 110.874 179.923 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.266 0 C-N-CA 120.763 -0.732 . . . . 24.53 112.47 -179.98 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.471 HG23 ' HB3' ' A' ' 5' ' ' TRP . 96.4 t . . . . . 0 C--O 1.23 0.046 0 CA-C-O 120.849 0.357 . . . . 73.510000000000005 111.136 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.663 ' HB3' ' CE1' ' A' ' 12' ' ' PHE . . . -120.82 -56.3 1.95 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.166 -0.47 . . . . 74.310000000000002 111.079 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 3.0 mtt180 -120.5 -74.2 0.62 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.456 . . . . 71.329999999999998 110.882 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.67 ' C ' HD21 ' A' ' 11' ' ' LEU . . . -117.82 1.93 17.53 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.774 -0.727 . . . . 63.140000000000001 112.489 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.471 ' HB3' HG23 ' A' ' 1' ' ' VAL . 0.0 OUTLIER -51.66 92.5 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.751 0.31 . . . . 75.409999999999997 110.951 -179.967 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -94.91 -79.51 1.46 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.723 -0.751 . . . . 62.149999999999999 112.487 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 12.9 mtm-85 -116.75 -78.67 0.58 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.83 0.348 . . . . 72.129999999999995 110.848 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.17 31.74 5.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.171 -0.468 . . . . 74.420000000000002 110.908 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.8 m -121.04 75.45 29.37 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.595 0.712 . . . . 64.430000000000007 110.891 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.446 ' HB3' ' CZ2' ' A' ' 5' ' ' TRP . 54.0 Cg_endo -69.76 132.09 22.6 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.696 2.264 . . . . 75.340000000000003 112.347 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.67 HD21 ' C ' ' A' ' 4' ' ' GLY . 0.3 OUTLIER -120.53 27.55 8.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 73.409999999999997 110.916 179.959 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.663 ' CE1' ' HB3' ' A' ' 2' ' ' ALA . 0.1 OUTLIER -123.73 26.78 7.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 74.219999999999999 110.938 179.907 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.265 0 C-N-CA 120.686 -0.768 . . . . 52.140000000000001 112.495 -179.964 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.478 HG23 ' HB3' ' A' ' 5' ' ' TRP . 96.5 t . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.845 0.355 . . . . 71.420000000000002 111.113 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.66 ' HB3' ' CE2' ' A' ' 12' ' ' PHE . . . -120.77 -56.32 1.95 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.456 . . . . 40.210000000000001 111.127 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 4.4 mtt180 -120.54 -74.13 0.62 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.464 . . . . 73.109999999999999 110.875 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.686 ' C ' HD21 ' A' ' 11' ' ' LEU . . . -117.89 2.07 17.35 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.735 -0.745 . . . . 63.43 112.48 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.478 ' HB3' HG23 ' A' ' 1' ' ' VAL . 0.0 OUTLIER -51.86 92.44 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.796 0.331 . . . . 73.019999999999996 110.927 -179.934 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -95.02 -80.19 1.49 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.727 -0.749 . . . . 73.010000000000005 112.509 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.57 -79.04 0.58 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.869 0.366 . . . . 73.439999999999998 110.921 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.25 32.31 5.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.464 . . . . 71.25 110.853 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 65.1 m -121.36 75.56 32.78 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.554 0.693 . . . . 64.140000000000001 110.833 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.45 ' HB3' ' CZ2' ' A' ' 5' ' ' TRP . 53.7 Cg_endo -69.75 132.15 22.74 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.637 2.225 . . . . 73.209999999999994 112.324 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.686 HD21 ' C ' ' A' ' 4' ' ' GLY . 0.3 OUTLIER -120.53 27.59 8.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.185 -0.461 . . . . 63.439999999999998 110.922 179.93 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.66 ' CE2' ' HB3' ' A' ' 2' ' ' ALA . 0.1 OUTLIER -123.79 25.99 7.84 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.162 -0.472 . . . . 65.340000000000003 110.913 179.897 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.28 0 C-N-CA 120.756 -0.735 . . . . 73.409999999999997 112.44 -179.95 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.48 HG23 ' HB3' ' A' ' 5' ' ' TRP . 96.7 t . . . . . 0 N--CA 1.458 -0.053 0 CA-C-O 120.856 0.36 . . . . 75.430000000000007 111.147 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.657 ' HB3' ' CE2' ' A' ' 12' ' ' PHE . . . -120.79 -56.26 1.96 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.136 -0.484 . . . . 43.32 111.096 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 4.8 mtt85 -120.58 -74.16 0.62 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.249 -0.432 . . . . 63.420000000000002 110.893 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.684 ' C ' HD21 ' A' ' 11' ' ' LEU . . . -117.85 2.03 17.44 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.765 -0.731 . . . . 71.420000000000002 112.492 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.48 ' HB3' HG23 ' A' ' 1' ' ' VAL . 0.0 OUTLIER -51.87 92.51 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.8 0.333 . . . . 75.510000000000005 110.903 -179.904 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -95.01 -80.24 1.5 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.738 -0.744 . . . . 72.450000000000003 112.5 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 11.2 mtp85 -115.55 -79.08 0.58 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.896 0.379 . . . . 75.019999999999996 110.874 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.2 32.28 5.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.161 -0.472 . . . . 65.319999999999993 110.897 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 82.8 m -121.36 75.57 32.71 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.603 0.716 . . . . 53.509999999999998 110.879 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.451 ' HB3' ' CZ2' ' A' ' 5' ' ' TRP . 53.8 Cg_endo -69.74 132.09 22.63 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.695 2.263 . . . . 74.329999999999998 112.371 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.684 HD21 ' C ' ' A' ' 4' ' ' GLY . 0.3 OUTLIER -120.48 27.54 8.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.214 -0.448 . . . . 74.510000000000005 110.899 179.987 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.657 ' CE2' ' HB3' ' A' ' 2' ' ' ALA . 0.1 OUTLIER -123.81 26.07 7.8 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.209 -0.45 . . . . 74.239999999999995 110.896 179.957 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.319 0 C-N-CA 120.751 -0.737 . . . . 63.520000000000003 112.459 -179.976 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.479 HG23 ' HB3' ' A' ' 5' ' ' TRP . 96.6 t . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.934 0.397 . . . . 73.239999999999995 111.15 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.65 ' HB3' ' CE2' ' A' ' 12' ' ' PHE . . . -120.85 -56.27 1.95 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.11 -0.495 . . . . 64.439999999999998 111.052 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 1.9 mtt180 -120.55 -74.2 0.62 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 75.310000000000002 110.869 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.687 ' C ' HD21 ' A' ' 11' ' ' LEU . . . -117.84 2.04 17.45 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.72 -0.752 . . . . 73.510000000000005 112.438 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.479 ' HB3' HG23 ' A' ' 1' ' ' VAL . 0.0 OUTLIER -51.83 92.48 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.823 0.344 . . . . 73.129999999999995 110.904 -179.903 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -95.04 -80.3 1.5 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.764 -0.731 . . . . 30.449999999999999 112.483 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.3 mtp180 -115.47 -79.08 0.58 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.907 0.384 . . . . 75.340000000000003 110.864 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.2 32.24 5.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 72.430000000000007 110.877 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 35.8 m -121.32 75.57 32.32 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.605 0.717 . . . . 64.140000000000001 110.901 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.447 ' HB3' ' CZ2' ' A' ' 5' ' ' TRP . 53.3 Cg_endo -69.79 132.12 22.61 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.707 2.272 . . . . 74.040000000000006 112.306 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.687 HD21 ' C ' ' A' ' 4' ' ' GLY . 0.3 OUTLIER -120.48 27.52 8.52 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.184 -0.462 . . . . 64.239999999999995 110.909 179.97 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.65 ' CE2' ' HB3' ' A' ' 2' ' ' ALA . 0.1 OUTLIER -123.79 26.77 7.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.451 . . . . 71.540000000000006 110.912 179.915 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 C-N-CA 120.72 -0.753 . . . . 62.340000000000003 112.507 -179.973 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.484 HG23 ' HB3' ' A' ' 5' ' ' TRP . 96.6 t . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.852 0.358 . . . . 73.099999999999994 111.145 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.652 ' HB3' ' CE2' ' A' ' 12' ' ' PHE . . . -120.77 -56.26 1.96 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.204 -0.453 . . . . 72.409999999999997 111.099 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -120.51 -74.25 0.62 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.217 -0.447 . . . . 73.150000000000006 110.852 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.685 ' C ' HD21 ' A' ' 11' ' ' LEU . . . -117.82 2.02 17.51 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.75 -0.738 . . . . 50.439999999999998 112.443 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.484 ' HB3' HG23 ' A' ' 1' ' ' VAL . 0.0 OUTLIER -51.86 92.42 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.783 0.325 . . . . 74.409999999999997 110.947 -179.917 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -94.98 -80.23 1.5 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.703 -0.761 . . . . 71.040000000000006 112.502 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 4.0 mtt85 -115.52 -79.05 0.58 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.924 0.392 . . . . 61.409999999999997 110.887 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.22 32.22 5.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 72.019999999999996 110.922 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 3.2 m -121.31 75.6 32.31 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.575 0.702 . . . . 71.25 110.87 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.443 ' HB3' ' CZ2' ' A' ' 5' ' ' TRP . 53.5 Cg_endo -69.78 132.17 22.74 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.692 2.262 . . . . 52.039999999999999 112.309 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.685 HD21 ' C ' ' A' ' 4' ' ' GLY . 0.3 OUTLIER -120.53 27.5 8.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.234 -0.439 . . . . 72.340000000000003 110.901 179.968 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.652 ' CE2' ' HB3' ' A' ' 2' ' ' ALA . 0.1 OUTLIER -123.76 26.22 7.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 63.420000000000002 110.911 179.943 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.318 0 C-N-CA 120.721 -0.752 . . . . 70.420000000000002 112.497 -179.941 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.474 HG23 ' HB3' ' A' ' 5' ' ' TRP . 96.6 t . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.811 0.338 . . . . 74.319999999999993 111.108 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.667 ' HB3' ' CE2' ' A' ' 12' ' ' PHE . . . -120.85 -56.33 1.95 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.133 -0.485 . . . . 70.409999999999997 111.108 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -120.49 -74.15 0.62 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 73.349999999999994 110.893 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.673 ' C ' HD21 ' A' ' 11' ' ' LEU . . . -117.96 2.11 17.17 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.712 -0.756 . . . . 70.450000000000003 112.45 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.474 ' HB3' HG23 ' A' ' 1' ' ' VAL . 0.0 OUTLIER -51.84 92.52 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.853 0.359 . . . . 54.149999999999999 110.938 -179.961 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -95.05 -80.21 1.5 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.762 -0.732 . . . . 74.549999999999997 112.497 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 44.7 mtt180 -115.62 -79.05 0.58 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.847 0.356 . . . . 71.329999999999998 110.873 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.25 32.25 5.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 74.319999999999993 110.89 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 72.4 m -121.33 75.57 32.4 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.625 0.726 . . . . 43.43 110.881 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.441 ' HB3' ' CZ2' ' A' ' 5' ' ' TRP . 53.7 Cg_endo -69.71 132.06 22.62 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.71 2.274 . . . . 73.420000000000002 112.365 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.673 HD21 ' C ' ' A' ' 4' ' ' GLY . 0.3 OUTLIER -120.48 27.57 8.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.282 -0.417 . . . . 63.5 110.897 179.97 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.667 ' CE2' ' HB3' ' A' ' 2' ' ' ALA . 0.1 OUTLIER -123.79 26.18 7.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 74.400000000000006 110.843 179.963 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.283 0 C-N-CA 120.735 -0.745 . . . . 24.41 112.446 -179.917 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.474 HG23 ' HB3' ' A' ' 5' ' ' TRP . 96.4 t . . . . . 0 N--CA 1.457 -0.091 0 CA-C-O 120.878 0.371 . . . . 72.109999999999999 111.136 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.66 ' HB3' ' CE1' ' A' ' 12' ' ' PHE . . . -120.8 -56.24 1.96 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.124 -0.489 . . . . 72.230000000000004 111.096 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 13.2 mtt85 -120.5 -74.3 0.62 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 73.299999999999997 110.861 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.684 ' C ' HD21 ' A' ' 11' ' ' LEU . . . -117.75 1.94 17.69 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.764 -0.731 . . . . 74.530000000000001 112.487 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.474 ' HB3' HG23 ' A' ' 1' ' ' VAL . 0.0 OUTLIER -51.83 92.44 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.795 0.331 . . . . 75.329999999999998 110.914 -179.877 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -94.99 -80.27 1.5 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.718 -0.753 . . . . 71.239999999999995 112.496 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 5.0 mtp180 -115.48 -79.05 0.58 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.863 0.363 . . . . 74.120000000000005 110.9 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.23 32.26 5.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.469 . . . . 75.219999999999999 110.875 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 33.9 m -121.38 75.58 32.95 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.621 0.724 . . . . 64.049999999999997 110.926 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.447 ' HB3' ' CZ2' ' A' ' 5' ' ' TRP . 54.0 Cg_endo -69.71 132.18 22.85 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.638 2.225 . . . . 71.310000000000002 112.359 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.684 HD21 ' C ' ' A' ' 4' ' ' GLY . 0.3 OUTLIER -120.52 27.53 8.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.218 -0.446 . . . . 73.329999999999998 110.906 179.979 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.66 ' CE1' ' HB3' ' A' ' 2' ' ' ALA . 0.1 OUTLIER -123.78 26.77 7.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 73.310000000000002 110.862 179.966 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.309 0 C-N-CA 120.706 -0.759 . . . . 52.119999999999997 112.464 -179.959 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.473 HG23 ' HB3' ' A' ' 5' ' ' TRP . 96.6 t . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.84 0.352 . . . . 63.439999999999998 111.143 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.662 ' HB3' ' CE1' ' A' ' 12' ' ' PHE . . . -120.77 -56.28 1.96 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 60.149999999999999 111.147 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -120.52 -74.21 0.62 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.19 -0.459 . . . . 72.120000000000005 110.882 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.674 ' C ' HD21 ' A' ' 11' ' ' LEU . . . -117.79 2.01 17.6 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.765 -0.731 . . . . 62.420000000000002 112.468 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.473 ' HB3' HG23 ' A' ' 1' ' ' VAL . 0.0 OUTLIER -51.88 92.45 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.813 0.34 . . . . 74.209999999999994 110.894 -179.894 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -94.98 -80.2 1.49 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.726 -0.749 . . . . 63.32 112.494 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 8.6 mtt180 -115.56 -79.06 0.58 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.916 0.389 . . . . 74.140000000000001 110.898 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.21 32.24 5.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.116 -0.493 . . . . 74.239999999999995 110.924 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 90.4 m -121.33 75.57 32.39 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.63 0.729 . . . . 72.030000000000001 110.88 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.441 ' HB3' ' CZ2' ' A' ' 5' ' ' TRP . 54.6 Cg_endo -69.7 132.06 22.63 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.736 2.291 . . . . 73.439999999999998 112.366 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.674 HD21 ' C ' ' A' ' 4' ' ' GLY . 0.3 OUTLIER -120.49 27.59 8.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.23 -0.441 . . . . 54.409999999999997 110.97 179.93 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.662 ' CE1' ' HB3' ' A' ' 2' ' ' ALA . 0.1 OUTLIER -123.83 26.33 7.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.47 . . . . 73.030000000000001 110.876 179.953 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 C-N-CA 120.726 -0.75 . . . . 62.009999999999998 112.454 -179.964 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.478 HG23 ' HB3' ' A' ' 5' ' ' TRP . 96.4 t . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.813 0.339 . . . . 72.200000000000003 111.087 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.659 ' HB3' ' CE1' ' A' ' 12' ' ' PHE . . . -120.78 -56.3 1.95 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.459 . . . . 74.230000000000004 111.092 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 19.7 mtt180 -120.56 -74.18 0.62 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.238 -0.437 . . . . 73.329999999999998 110.904 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.684 ' C ' HD21 ' A' ' 11' ' ' LEU . . . -117.87 2.08 17.39 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.704 -0.76 . . . . 61.210000000000001 112.461 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.478 ' HB3' HG23 ' A' ' 1' ' ' VAL . 0.0 OUTLIER -51.87 92.43 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.798 0.333 . . . . 74.420000000000002 110.92 -179.921 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -95.01 -80.24 1.5 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.758 -0.734 . . . . 44.329999999999998 112.486 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 3.1 mtt180 -115.51 -79.08 0.58 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.84 0.353 . . . . 73.099999999999994 110.883 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.21 32.25 5.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.449 . . . . 71.430000000000007 110.874 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.6 m -121.34 75.64 32.58 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.629 0.728 . . . . 64.129999999999995 110.901 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.441 ' HB3' ' CZ2' ' A' ' 5' ' ' TRP . 54.0 Cg_endo -69.77 132.11 22.62 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.648 2.232 . . . . 64.510000000000005 112.349 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.684 HD21 ' C ' ' A' ' 4' ' ' GLY . 0.3 OUTLIER -120.44 27.46 8.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.231 -0.44 . . . . 71.140000000000001 110.955 179.971 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.659 ' CE1' ' HB3' ' A' ' 2' ' ' ALA . 0.1 OUTLIER -123.79 26.77 7.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 73.540000000000006 110.893 179.946 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.318 0 C-N-CA 120.748 -0.739 . . . . 33.32 112.497 -179.984 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.477 HG23 ' HB3' ' A' ' 5' ' ' TRP . 96.4 t . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.84 0.352 . . . . 73.430000000000007 111.076 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.651 ' HB3' ' CE1' ' A' ' 12' ' ' PHE . . . -120.83 -56.2 1.96 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.194 -0.457 . . . . 74.049999999999997 111.095 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 12.7 mtp180 -120.6 -74.17 0.62 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.45 . . . . 75.0 110.838 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.685 ' C ' HD21 ' A' ' 11' ' ' LEU . . . -117.83 2.04 17.49 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.777 -0.725 . . . . 61.140000000000001 112.491 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.477 ' HB3' HG23 ' A' ' 1' ' ' VAL . 0.0 OUTLIER -51.93 92.54 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.841 0.353 . . . . 74.340000000000003 110.917 -179.874 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -95.03 -80.21 1.49 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.69 -0.767 . . . . 73.510000000000005 112.472 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 2.6 mtp85 -115.58 -79.01 0.58 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.882 0.373 . . . . 71.219999999999999 110.883 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.26 32.21 5.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 74.230000000000004 110.886 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 77.7 m -121.32 75.58 32.34 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.555 0.693 . . . . 74.319999999999993 110.86 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.447 ' HB3' ' CZ2' ' A' ' 5' ' ' TRP . 53.6 Cg_endo -69.77 132.11 22.63 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.675 2.25 . . . . 75.439999999999998 112.333 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.685 HD21 ' C ' ' A' ' 4' ' ' GLY . 0.3 OUTLIER -120.46 27.52 8.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 75.519999999999996 110.902 179.957 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.651 ' CE1' ' HB3' ' A' ' 2' ' ' ALA . 0.1 OUTLIER -123.76 26.54 7.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.446 . . . . 72.540000000000006 110.824 179.991 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 C-N-CA 120.771 -0.728 . . . . 64.319999999999993 112.475 -179.954 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.478 HG23 ' HB3' ' A' ' 5' ' ' TRP . 96.6 t . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.896 0.379 . . . . 72.200000000000003 111.146 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.658 ' HB3' ' CE1' ' A' ' 12' ' ' PHE . . . -120.85 -56.27 1.95 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.184 -0.462 . . . . 72.129999999999995 111.088 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 21.2 mtt180 -120.52 -74.17 0.62 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.258 -0.428 . . . . 74.409999999999997 110.876 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.684 ' C ' HD21 ' A' ' 11' ' ' LEU . . . -117.85 2.01 17.44 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.706 -0.759 . . . . 14.529999999999999 112.49 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.478 ' HB3' HG23 ' A' ' 1' ' ' VAL . 0.0 OUTLIER -51.82 92.51 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.81 0.338 . . . . 71.209999999999994 110.921 -179.923 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -95.06 -80.19 1.49 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.754 -0.736 . . . . 71.150000000000006 112.461 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -115.61 -79.11 0.58 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.886 0.374 . . . . 72.420000000000002 110.841 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.21 32.25 5.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.162 -0.472 . . . . 73.030000000000001 110.866 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 61.9 m -121.31 75.52 32.22 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.63 0.729 . . . . 73.239999999999995 110.909 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.447 ' HB3' ' CZ2' ' A' ' 5' ' ' TRP . 54.4 Cg_endo -69.69 132.02 22.56 Favored 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.744 2.296 . . . . 70.310000000000002 112.361 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.684 HD21 ' C ' ' A' ' 4' ' ' GLY . 0.3 OUTLIER -120.46 27.59 8.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.254 -0.43 . . . . 75.209999999999994 110.911 179.978 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.658 ' CE1' ' HB3' ' A' ' 2' ' ' ALA . 0.1 OUTLIER -123.8 26.12 7.78 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.231 -0.44 . . . . 55.450000000000003 110.875 179.951 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.262 0 C-N-CA 120.701 -0.761 . . . . 34.130000000000003 112.476 -179.967 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.479 HG23 ' HB3' ' A' ' 5' ' ' TRP . 96.5 t . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.86 0.362 . . . . 63.009999999999998 111.128 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.656 ' HB3' ' CE1' ' A' ' 12' ' ' PHE . . . -120.81 -56.29 1.95 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.137 -0.483 . . . . 71.209999999999994 111.083 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 1.9 mtt180 -120.55 -74.19 0.62 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.235 -0.439 . . . . 62.25 110.89 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.678 ' C ' HD21 ' A' ' 11' ' ' LEU . . . -117.81 2.08 17.52 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.745 -0.74 . . . . 62.210000000000001 112.498 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.479 ' HB3' HG23 ' A' ' 1' ' ' VAL . 0.0 OUTLIER -51.91 92.49 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.851 0.358 . . . . 74.299999999999997 110.869 -179.893 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -94.96 -80.25 1.5 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.776 -0.726 . . . . 64.340000000000003 112.478 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 56.3 mtm180 -115.6 -79.01 0.58 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.919 0.39 . . . . 73.329999999999998 110.916 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.24 32.22 5.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.16 -0.473 . . . . 74.439999999999998 110.908 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 82.6 m -121.34 75.59 32.52 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.623 0.725 . . . . 61.009999999999998 110.912 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.448 ' HB3' ' CZ2' ' A' ' 5' ' ' TRP . 53.7 Cg_endo -69.78 132.05 22.49 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.719 2.279 . . . . 72.340000000000003 112.338 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.678 HD21 ' C ' ' A' ' 4' ' ' GLY . 0.3 OUTLIER -120.47 27.53 8.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 74.340000000000003 110.901 179.991 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.656 ' CE1' ' HB3' ' A' ' 2' ' ' ALA . 0.1 OUTLIER -123.79 26.47 7.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.227 -0.442 . . . . 73.409999999999997 110.852 179.945 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.27 0 C-N-CA 120.714 -0.755 . . . . 73.140000000000001 112.465 -179.971 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.484 HG23 ' HB3' ' A' ' 5' ' ' TRP . 96.5 t . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.843 0.354 . . . . 72.420000000000002 111.183 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.662 ' HB3' ' CE2' ' A' ' 12' ' ' PHE . . . -120.82 -56.31 1.95 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.167 -0.47 . . . . 73.230000000000004 111.105 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 48.2 mtt180 -120.53 -74.21 0.62 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.45 . . . . 75.230000000000004 110.865 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.672 ' C ' HD21 ' A' ' 11' ' ' LEU . . . -117.84 2.05 17.46 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.717 -0.754 . . . . 74.230000000000004 112.497 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.484 ' HB3' HG23 ' A' ' 1' ' ' VAL . 0.0 OUTLIER -51.88 92.53 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.838 0.351 . . . . 71.109999999999999 110.898 -179.907 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -95.0 -80.47 1.51 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.761 -0.733 . . . . 50.140000000000001 112.472 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.33 -79.0 0.58 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.838 0.352 . . . . 74.430000000000007 110.879 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.31 32.31 5.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.204 -0.453 . . . . 72.129999999999995 110.925 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.3 m -121.4 75.6 33.15 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.617 0.722 . . . . 54.109999999999999 110.878 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.452 ' HB3' ' CZ2' ' A' ' 5' ' ' TRP . 54.0 Cg_endo -69.72 132.1 22.68 Favored 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.682 2.255 . . . . 65.349999999999994 112.391 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.672 HD21 ' C ' ' A' ' 4' ' ' GLY . 0.3 OUTLIER -120.47 27.59 8.49 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.288 -0.414 . . . . 75.230000000000004 110.971 179.948 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.662 ' CE2' ' HB3' ' A' ' 2' ' ' ALA . 0.1 OUTLIER -123.81 26.6 7.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 75.209999999999994 110.901 179.919 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.38 0 C-N-CA 120.753 -0.737 . . . . 73.450000000000003 112.52 -179.984 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.48 HG23 ' HB3' ' A' ' 5' ' ' TRP . 96.5 t . . . . . 0 N--CA 1.457 -0.079 0 CA-C-O 120.862 0.363 . . . . 52.43 111.14 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.66 ' HB3' ' CE1' ' A' ' 12' ' ' PHE . . . -120.81 -56.27 1.95 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.466 . . . . 75.019999999999996 111.082 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -120.5 -74.2 0.62 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.254 -0.43 . . . . 75.319999999999993 110.895 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.679 ' C ' HD21 ' A' ' 11' ' ' LEU . . . -117.86 2.02 17.42 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.725 -0.75 . . . . 51.0 112.532 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.48 ' HB3' HG23 ' A' ' 1' ' ' VAL . 0.0 OUTLIER -51.83 92.5 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.792 0.329 . . . . 63.020000000000003 110.902 -179.913 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -94.98 -80.29 1.5 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.754 -0.736 . . . . 60.43 112.52 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 11.2 mtt180 -115.57 -78.98 0.58 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.891 0.377 . . . . 75.510000000000005 110.81 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.31 32.26 5.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.451 . . . . 74.310000000000002 110.917 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 84.2 m -121.36 75.61 32.79 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.638 0.732 . . . . 60.32 110.894 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.442 ' HB3' ' CZ2' ' A' ' 5' ' ' TRP . 53.5 Cg_endo -69.81 132.1 22.55 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.692 2.262 . . . . 64.430000000000007 112.327 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.679 HD21 ' C ' ' A' ' 4' ' ' GLY . 0.3 OUTLIER -120.43 27.54 8.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 64.319999999999993 110.919 179.969 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.66 ' CE1' ' HB3' ' A' ' 2' ' ' ALA . 0.1 OUTLIER -123.77 26.09 7.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 70.239999999999995 110.868 179.967 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 C-N-CA 120.712 -0.756 . . . . 60.140000000000001 112.509 -179.973 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.487 HG23 ' HB3' ' A' ' 5' ' ' TRP . 96.1 t . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.809 0.338 . . . . 64.140000000000001 111.12 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.643 ' HB3' ' CE2' ' A' ' 12' ' ' PHE . . . -120.76 -56.22 1.96 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.24 -0.436 . . . . 73.420000000000002 111.124 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 5.3 mtt180 -120.57 -73.96 0.63 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.459 . . . . 73.209999999999994 110.895 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.686 ' C ' HD21 ' A' ' 11' ' ' LEU . . . -118.19 2.05 16.64 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.742 -0.742 . . . . 61.130000000000003 112.494 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.487 ' HB3' HG23 ' A' ' 1' ' ' VAL . 0.0 OUTLIER -51.86 91.97 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.813 0.34 . . . . 75.140000000000001 110.969 -179.936 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -93.71 -81.15 1.5 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.738 -0.744 . . . . 73.209999999999994 112.516 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.72 -77.83 0.57 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.839 0.352 . . . . 72.030000000000001 110.875 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.51 31.86 5.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 73.25 110.867 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 43.0 m -121.3 75.35 31.92 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.598 0.713 . . . . 73.140000000000001 110.864 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.458 ' HB3' ' CZ2' ' A' ' 5' ' ' TRP . 54.0 Cg_endo -69.8 132.36 23.11 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.645 2.23 . . . . 51.229999999999997 112.336 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.686 HD21 ' C ' ' A' ' 4' ' ' GLY . 0.3 OUTLIER -120.57 27.55 8.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.204 -0.453 . . . . 65.439999999999998 110.884 179.989 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.643 ' CE2' ' HB3' ' A' ' 2' ' ' ALA . 0.1 OUTLIER -123.81 26.66 7.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 61.229999999999997 110.87 179.927 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.299 0 C-N-CA 120.752 -0.737 . . . . 63.43 112.481 -179.973 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.487 HG23 ' HB3' ' A' ' 5' ' ' TRP . 96.0 t . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.868 0.366 . . . . 65.120000000000005 111.108 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.646 ' HB3' ' CE1' ' A' ' 12' ' ' PHE . . . -120.74 -56.26 1.96 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 60.009999999999998 111.072 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.49 -74.06 0.62 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.19 -0.459 . . . . 74.319999999999993 110.874 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.684 ' C ' HD21 ' A' ' 11' ' ' LEU . . . -118.16 2.18 16.67 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.717 -0.754 . . . . 72.109999999999999 112.47 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.487 ' HB3' HG23 ' A' ' 1' ' ' VAL . 0.0 OUTLIER -51.93 92.06 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.807 0.337 . . . . 65.5 110.925 -179.942 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -93.8 -81.29 1.5 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.72 -0.752 . . . . 61.420000000000002 112.493 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 2.9 ttt180 -115.44 -77.84 0.57 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.872 0.368 . . . . 73.409999999999997 110.914 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.61 31.89 5.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 73.319999999999993 110.879 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 2.6 m -121.27 75.38 31.64 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.62 0.724 . . . . 71.030000000000001 110.894 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.456 ' HB3' ' CZ2' ' A' ' 5' ' ' TRP . 53.7 Cg_endo -69.75 132.27 23.0 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.691 2.261 . . . . 62.119999999999997 112.324 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.684 HD21 ' C ' ' A' ' 4' ' ' GLY . 0.3 OUTLIER -120.52 27.58 8.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 74.319999999999993 110.934 179.946 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.646 ' CE1' ' HB3' ' A' ' 2' ' ' ALA . 0.1 OUTLIER -123.78 26.19 7.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 44.219999999999999 110.902 179.942 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.34 0 C-N-CA 120.795 -0.717 . . . . 63.420000000000002 112.49 -179.934 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.491 HG23 ' HB3' ' A' ' 5' ' ' TRP . 96.5 t . . . . . 0 C--O 1.23 0.06 0 CA-C-O 120.849 0.356 . . . . 63.210000000000001 111.12 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.657 ' HB3' ' CE2' ' A' ' 12' ' ' PHE . . . -120.71 -56.41 1.96 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.168 -0.469 . . . . 75.140000000000001 111.104 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -120.47 -74.38 0.61 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.216 -0.447 . . . . 62.43 110.871 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.675 ' C ' HD21 ' A' ' 11' ' ' LEU . . . -117.56 2.15 18.11 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.753 -0.737 . . . . 62.329999999999998 112.54 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.491 ' HB3' HG23 ' A' ' 1' ' ' VAL . 0.0 OUTLIER -51.75 92.9 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.829 0.347 . . . . 65.010000000000005 110.908 -179.923 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -95.15 -77.49 1.37 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.782 -0.723 . . . . 52.210000000000001 112.45 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.33 -77.57 0.58 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.939 0.399 . . . . 72.049999999999997 110.903 -179.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.95 31.36 5.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.179 -0.464 . . . . 71.319999999999993 110.881 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 57.2 m -121.13 74.85 29.41 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.608 0.718 . . . . 72.540000000000006 110.902 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.457 ' HB3' ' CZ2' ' A' ' 5' ' ' TRP . 53.6 Cg_endo -69.74 131.89 22.23 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.695 2.263 . . . . 71.099999999999994 112.346 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.675 HD21 ' C ' ' A' ' 4' ' ' GLY . 0.3 OUTLIER -120.6 27.22 8.67 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.216 -0.447 . . . . 74.430000000000007 110.958 179.942 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.657 ' CE2' ' HB3' ' A' ' 2' ' ' ALA . 0.1 OUTLIER -123.84 26.37 7.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.18 -0.464 . . . . 75.049999999999997 110.889 179.935 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.34 0 C-N-CA 120.715 -0.755 . . . . 73.549999999999997 112.472 -179.989 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.487 HG23 ' HB3' ' A' ' 5' ' ' TRP . 97.0 t . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.812 0.339 . . . . 73.230000000000004 111.14 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.671 ' HB3' ' CE2' ' A' ' 12' ' ' PHE . . . -120.74 -56.39 1.95 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 64.310000000000002 111.087 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 3.0 mtp180 -120.46 -74.49 0.61 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.225 -0.443 . . . . 73.230000000000004 110.867 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.664 ' C ' HD21 ' A' ' 11' ' ' LEU . . . -117.5 2.13 18.26 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.723 -0.751 . . . . 65.099999999999994 112.457 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.487 ' HB3' HG23 ' A' ' 1' ' ' VAL . 0.0 OUTLIER -51.75 93.06 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.802 0.335 . . . . 74.040000000000006 110.924 -179.938 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -95.68 -77.46 1.37 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.784 -0.722 . . . . 70.299999999999997 112.489 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -119.76 -78.17 0.59 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.92 0.391 . . . . 73.129999999999995 110.914 -179.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.85 31.74 5.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.169 -0.469 . . . . 51.420000000000002 110.907 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 62.1 m -121.31 75.05 31.61 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.622 0.725 . . . . 64.510000000000005 110.9 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.443 ' HB3' ' CZ2' ' A' ' 5' ' ' TRP . 53.7 Cg_endo -69.79 131.82 21.99 Favored 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.694 2.263 . . . . 61.329999999999998 112.309 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.664 HD21 ' C ' ' A' ' 4' ' ' GLY . 0.3 OUTLIER -120.63 27.24 8.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 74.409999999999997 110.879 179.976 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.671 ' CE2' ' HB3' ' A' ' 2' ' ' ALA . 0.1 OUTLIER -123.87 26.61 7.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.214 -0.448 . . . . 74.450000000000003 110.894 179.914 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.262 0 C-N-CA 120.685 -0.769 . . . . 42.219999999999999 112.46 -179.99 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 92.1 t . . . . . 0 C--O 1.23 0.058 0 CA-C-O 120.82 0.343 . . . . 71.209999999999994 111.084 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.547 ' HB3' ' CE1' ' A' ' 12' ' ' PHE . . . -120.49 -58.5 1.84 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 74.329999999999998 111.115 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.599 ' HD3' HD12 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -121.38 -70.79 0.76 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.215 -0.448 . . . . 62.329999999999998 110.865 -179.883 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.732 ' C ' HD21 ' A' ' 11' ' ' LEU . . . -120.61 5.28 11.75 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.74 -0.743 . . . . 73.010000000000005 112.488 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.494 ' CZ2' ' HB3' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -58.87 82.38 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.803 0.335 . . . . 74.010000000000005 110.879 -179.899 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' A' ' 4' ' ' GLY . . . -84.97 -95.69 0.71 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.731 -0.747 . . . . 73.219999999999999 112.446 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 15.1 mtp180 -99.07 -79.09 0.49 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.863 0.363 . . . . 62.229999999999997 110.869 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.39 33.16 5.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.205 -0.452 . . . . 75.409999999999997 110.887 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 86.6 m -120.48 72.28 19.94 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.609 0.719 . . . . 73.519999999999996 110.873 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.494 ' HB3' ' CZ2' ' A' ' 5' ' ' TRP . 54.0 Cg_endo -69.8 136.68 33.51 Favored 'Trans proline' 0 N--CA 1.465 -0.171 0 C-N-CA 122.725 2.283 . . . . 63.140000000000001 112.365 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.732 HD21 ' C ' ' A' ' 4' ' ' GLY . 0.2 OUTLIER -121.41 29.26 7.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.24 -0.436 . . . . 73.299999999999997 110.93 179.971 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.547 ' CE1' ' HB3' ' A' ' 2' ' ' ALA . 0.2 OUTLIER -122.1 27.58 7.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 64.040000000000006 110.907 179.944 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.344 0 C-N-CA 120.741 -0.742 . . . . 62.229999999999997 112.528 -179.966 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 93.1 t . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.783 0.325 . . . . 72.109999999999999 111.11 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.536 ' HB3' ' CE1' ' A' ' 12' ' ' PHE . . . -120.51 -58.32 1.85 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.466 . . . . 74.200000000000003 111.071 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.609 ' HD3' HD12 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -121.36 -70.96 0.75 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.232 -0.44 . . . . 72.319999999999993 110.872 -179.895 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.734 ' C ' HD21 ' A' ' 11' ' ' LEU . . . -120.62 5.46 11.7 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.714 -0.755 . . . . 65.010000000000005 112.461 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.487 ' CZ2' ' HB3' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -58.96 82.31 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.799 0.333 . . . . 71.099999999999994 110.958 -179.929 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' A' ' 4' ' ' GLY . . . -85.2 -96.54 0.72 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.749 -0.738 . . . . 75.430000000000007 112.518 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.49 -79.68 0.46 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.869 0.366 . . . . 62.549999999999997 110.883 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.49 33.9 4.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.176 -0.466 . . . . 70.430000000000007 110.909 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 46.0 m -120.91 72.44 22.72 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.626 0.727 . . . . 73.409999999999997 110.861 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.487 ' HB3' ' CZ2' ' A' ' 5' ' ' TRP . 53.9 Cg_endo -69.76 136.54 33.26 Favored 'Trans proline' 0 N--CA 1.465 -0.198 0 C-N-CA 122.724 2.282 . . . . 75.400000000000006 112.383 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.734 HD21 ' C ' ' A' ' 4' ' ' GLY . 0.2 OUTLIER -121.37 29.36 7.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.221 -0.445 . . . . 72.519999999999996 110.942 -179.995 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.543 ' N ' ' CD2' ' A' ' 12' ' ' PHE . 0.2 OUTLIER -122.19 27.14 8.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.167 -0.469 . . . . 64.209999999999994 110.874 179.923 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.266 0 C-N-CA 120.763 -0.732 . . . . 24.530000000000001 112.47 -179.98 . . . . . . . . 0 0 . 1 stop_ save_